This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
The drug store chain reported second-quarter earnings on March 27 of $683 million, or 78 cents a share, down from year-earlier earnings of $739 million, or 80 cents.
"ESRX noted the exclusion of Walgreens had a benefit to mail volumes," Oppenheimer analysts wrote in a May 14 report. "Mail scripts came in 0.6M/1.0M better than our/consensus estimates. Several Medco clients have elected to pre-empt the discussion of whether WAG will remain an option in the Medco book of business, opting for a retail network excluding WAG."
Forward Annual Dividend Yield: 2.7%